Self-Identified Effective Strategies for the Management of Adverse Drug Reactions to First-Line Anti-Tuberculosis Drugs
Abstract
Objective: Adverse drug reactions are important factors in patients’ discontinuation of antituberculosis drugs. Therefore, managing adverse drug reactions is vital to reducing the risk of tuberculosis transmission due to premature discontinuation of medications and increasing the chances of treatment success. We sought to explore self-identified, effective strategies for managing adverse drug reactions among newly diagnosed pulmonary tuberculosis patients.
Material and Methods: This was a cross-sectional survey investigating the symptom management of adverse drug reactions among newly diagnosed pulmonary tuberculosis patients using first-line antituberculosis drugs.
Results: Participants (n=394) reported the three highest-rated, self-identified, and effective strategies based on mean scores, enabling them to continue taking antituberculosis drugs, were: 1) Applying cold powder to manage itching (mean±S.D.=3.58±0.79), 2) Eating sour fruit to manage nausea (mean±S.D.=3.11±0.87), and 3) Eating small, frequent meals to manage decreased appetite (mean±S.D.=3.15±0.69).
Conclusion: Self-identified effective strategies for adverse antituberculosis drug reactions can help patients continue taking antituberculosis drugs, decreasing disease severity.
Keywords
Full Text:
PDF (Early Version)References
World Health Organization. Global tuberculosis report 2025 [homepage on the Internet]. Geneva: WHO; 2025 [cited 2026 Jan 9]. Available from: https://iris.who.int/server/api/core/bitstreams/e97dd6f4-b567-4396-8680-717bac6869a9/content
Department of Disease Control. Report on the national tuberculosis information program [homepage on the Internet]. Nonthaburi: Department of Disease Control, Ministry of Public Health; 2025 [cited 2026 Jan 9]. Available from: https://dvis3.ddc.moph.go.th/t/DDC_CENTER_DTB/views/FollowTB/Status_TB
Division of Tuberculosis. Tuberculosis situation and strategy. In: National Tuberculosis Control Programme Guideline, Thailand 2021. Nonthaburi: Aksorn Graphic and design publishing; 2021;p. 17-28.
World Health Organization. International drug monitoring: the role of national centers. Technical Report Series No. 498. Geneva: WHO; 1972.
Kaufman G. Adverse drug reactions: classification, susceptibility and reporting. Nurs Stand 2016;30:53–63.
Zazzara MB, Palmer K, Vetrano DL, Carfì A, Onder G. Adverse drug reactions in older adults: a narrative review of the literature. Eur Geriatr Med 2021;12:463-73.
World Health Organization. Consolidated guidelines on tuberculosis. Module 4: treatment - drug-susceptible tuberculosis treatment [homepage on the Internet]. Geneva: WHO; 2022 [cited 2026 Jan 9]. Available from: https://www.who.int/publications/i/item/9789240048126
Prasad R, Singh A, Gupta N. Adverse drug reactions with first line and second-line drugs in treatment of tuberculosis. Ann Natl Acad Med Sci 2021;57:16-35.
Amalba A, Bugri AA. Assessing the prevalence and effect of adverse drug reactions among patients receiving first line anti-tubercular medicines in the Tamale Teaching Hospital, Ghana. Pan Afr Med J 2021;38.
Singh A, Prasad R, Balasubramanian V, Gupta N, Gupta P. Prevalence of adverse drug reaction with first-line drugs among patients treated for pulmonary tuberculosis. Clin Epidemiol Glob Health 2015;3:S80-90.
Zegeye A, Dessie G, Wagnew F, et al. Prevalence and determinants of anti-tuberculosis treatment non-adherence in Ethiopia: a systematic review and meta-analysis. PloS One 2019;14:e0210422.
Joshi K, Tongaonkar A, Mulkalwar A, Goyal A. Analysis of burden and outcomes of anti-tuberculosis therapy-induced adverse drug effects at a tertiary care center. Asian J Med Sci 2022;13:192–8.
Aggarwal AN. Quality of life with tuberculosis. J Clin Tuberc Other Mycobact Dis 2019;17:1-9.
Massud A, Syed Sulaiman SA, Ahmad N, et al. Frequency and management of adverse drug reactions among drug-resistant tuberculosis patients: analysis from a prospective study. Front Pharmacol 2022;13:883483.
Prasad R, Singh A, Gupta N. Adverse drug reactions in tuberculosis and management. Indian J Tuberc 2019;66:520–32.
Thongsaman A, Janpanish P, Sumdaengrit B. Symptom experiences, symptom management strategies and outcomes related to adverse drug reactions of anti-tb drugs. Vajira Nurs J 2018;18:51–63.
Dodd M, Janson S, Facione N, et al. Advancing the science of symptom management. J Adv Nurs 2001;33:668–76.
Grove SK, Gray J. Understanding nursing research: Building an evidence-based practice. St. Louis (MO): Elsevier; 2020.
Polit DF, Beck CT, Owen SV. Is the CVI an acceptable indicator of content validity? Appraisal and recommendations. Res Nurs Health 2007;30:459–67.
LoBiondo-Wood G, Haber J. Nursing research: Methods and critical appraisal for evidence-based practice. 9th ed. Mosby Elsevier; 2022.
Srisatidnarakul B. The methodology in nursing research. 5th ed. Bangkok: Printing house You and I Inter Media Company; 2010.
Department of City Planning. Final report of the project on BMA central city planning. Bangkok: Department of City Planning, BMA; 2011.
Gray JR, Grove SK, Sutherland S. Burns and Grove’s the practice of nursing research: appraisal, synthesis, and generation of evidence. 9th ed. St. Louis: Elsevier; 2021.
Chautrakarn S, Khumros W, Phutrakool P. Self-medication with over-the-counter medicines among the working age population in metropolitan areas of Thailand. Front Pharmacol 2021;12:726643.
Peloquin CA, Durbin D, Childs J, Sterling TR, Weiner M. Stability of antituberculosis drugs mixed in food. Clin Infect Dis 2007;45:521.
Kaleem M, Ahmad A. Flavonoids as Nutraceuticals. In: Grumezescu AM, Holban AM, editors. Therapeutic, Probiotic, and Unconventional Foods. Academic Press; 2018;p.137-55.
World Health Organization. FAQs: frequently asked questions about tuberculosis [homepage on the Internet]. Geneva: WHO; 2013 [cited 2026 Jan 9]. Available from: https://apps.who.int/iris/handle/10665/205081
Lima MTM, Maruyama TC, Custódio IDD, et al. The impact of a higher eating frequency on the diet quality and nutritional status of women with breast cancer undergoing chemotherapy. Br J Nutr 2020;123:410–18.
Dashti HS, Mogensen KM. Recommending small, frequent meals in the clinical care of adults: a review of the evidence and important considerations. Nutr Clin Pract 2017;32:365–77.
Jakše B, Jakše B, Pajek M, Pajek J. Uric Acid and Plant-Based Nutrition. Nutrients 2019;11:1736.
Barnard J, Roberts S, Lastella M, Aisbett B, Condo D. The impact of dietary factors on the sleep of athletically trained populations: a systematic review. Nutrients 2022;14:3271.
O’Callaghan F, Muurlink O, Reid N. Effects of caffeine on sleep quality and daytime functioning. Risk Manag Healthc Policy 2018;11:263–71.
Liu B, Jordt SE. Cooling the Itch via TRPM8. J Invest Dermatol 2018;138:1254–6.
Pergolizzi JV, Taylor R, LeQuang JA, Raffa RB. The role and mechanism of action of menthol in topical analgesic products. J Clin Pharm Ther 2018;43:313–9.
Chatchawan U, Jarasrungsichol K, Yamauchi J. Immediate effects of self-Thai foot massage on skin blood flow, skin temperature, and range of motion of the foot and ankle in type 2 diabetic patients. J Altern Complement Med 2020;26:491–500.
Papoui E, Papastavrou E, Merkouris A, Charalambous A. A pilot randomized controlled study of the effects of an educational training program on skin reactions induced by chemotherapy, Epidermal Growth Factor Inhibitor (EGFRI) treatments, and immunotherapy. Eur J Oncol Nurs 2022;60:102194.
Jiajia B, Ling Z, Xiang Q. Observation of drug-induced liver damage caused by chemotherapy of pulmonary tuberculosis and analysis of its nursing effect. Acta Microsc 2020;29:2266–72.
World Health Organization. Management of MDR-TB: A Field Guide [homepage on the Internet]. Geneva: WHO; 2009 [cited 2026 Jan 9]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK310804/
Singh P, Yoon SS, Kuo B. Nausea: a review of pathophysiology and therapeutics. Ther Adv Gastroenterol 2016;9:98–112.
Hinkelmann JV, Possa LO, de Oliveira CA, et al. Food preferences and aversions of patients undergoing chemotherapy, radiotherapy and/or hematopoietic stem cell transplantation. Clin Nutr ESPEN 2021;44:331–6.
Ständer S, Augustin M, Roggenkamp D, et al. Novel TRPM8 agonist cooling compound against chronic itch: results from a randomized, double-blind, controlled, pilot study in dry skin. J Eur Acad Dermatol Venereol 2017;31:1064–8.
Misery L, Weisshaar E, Brenaut E, et al. Pathophysiology and management of sensitive skin: position paper from the special interest group on sensitive skin of the International Forum for the Study of Itch (IFSI). J Eur Acad Dermatol Venereol 2020;34:222–9.
El Soury M, Fornasari BE, Carta G, et al. The role of dietary nutrients in peripheral nerve regeneration. Int J Mol Sci 2021;22:7417.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.